Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: Sept. 25, 2013 | Contract Pharma

What are you searching for?

Sign in
Online Exclusives

Trials & Filings in Brief: Sept. 25, 2013

Acorda, Amarin, Bayer, Cardiome, Cornerstone, KemPharm, Merck Serono and Mylan

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II
Cornerstone begins trial for myelodysplastic syndrome . . . read more

Acorda enrolls for spinal injury trial . . . read more

Phase III
Merck Serono to conduct cancer immunotherapy trial . . . read more

Generics
Mylan sued over first-to-file challenge of Savella . . . read more

Outcomes
Amarin enrolls 6,000+ in REDUCE-IT CV trial . . . read more

Approvals
Cardiome gains Brinavess approval in Turkey . . . read more

Bioequivalence
KemPharm’s abuse-resistant opioid shows equivalence to RLD . . . read more

Filings
Bayer receives orphan status for riociguat . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics